Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioGross MarginInvested CapitalMarket Capitalization

Mainz Biomed N.V (MYNZ) Net Margin: 2022-2023

Historic Net Margin for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to -2,413.53%.

  • Mainz Biomed N.V's Net Margin rose 182313.00% to -2,413.53% in Q4 2023 from the same period last year, while for Dec 2023 it was -2,936.50%, marking a year-over-year increase of 204340.00%. This contributed to the annual value of -2,421.80% for FY2024, which is 52015.00% up from last year.
  • According to the latest figures from Q4 2023, Mainz Biomed N.V's Net Margin is -2,413.53%, which was up 30.40% from -3,467.71% recorded in Q3 2023.
  • Over the past 5 years, Mainz Biomed N.V's Net Margin peaked at -2,413.53% during Q4 2023, and registered a low of -5,781.76% during Q3 2022.
  • In the last 2 years, Mainz Biomed N.V's Net Margin had a median value of -3,852.19% in 2023 and averaged -4,056.60%.
  • Data for Mainz Biomed N.V's Net Margin shows a peak YoY soared of 300,864bps (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows Mainz Biomed N.V's Net Margin stood at -4,236.66% in 2022, then soared by 182,313bps to -2,413.53% in 2023.
  • Its Net Margin stands at -2,413.53% for Q4 2023, versus -3,467.71% for Q3 2023 and -3,314.68% for Q2 2023.